Corline Biomedical AB (CLBIO) — Cash Flow Reinvestment Rate
Corline Biomedical AB (CLBIO) has a Cash Flow Reinvestment Rate of 1.60x as of March 2024, reinvesting Skr3.67 Million (capex Skr1.83 Million plus investments Skr-1.83 Million) from operating cash flow of Skr2.30 Million. Explore CLBIO capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Corline Biomedical AB Cash Flow Reinvestment Rate (2023–2023)
Historical reinvestment intensity for Corline Biomedical AB across 1 annual periods. Also explore CLBIO total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Corline Biomedical AB (2023–2023)
Year-by-year capital reinvestment analysis for Corline Biomedical AB. For live market cap and broader valuation context, see how much is Corline Biomedical AB worth.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 23.23x | Skr20.59 Million | Skr886.00K | Skr10.62 Million | — |